Compare IFRX & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IFRX | INTG |
|---|---|---|
| Founded | 2007 | 1965 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.6M | 59.3M |
| IPO Year | 2017 | 1995 |
| Metric | IFRX | INTG |
|---|---|---|
| Price | $0.93 | $30.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 342.3K | 6.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | N/A | ★ $74,753,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,054.36 | N/A |
| P/E Ratio | ★ N/A | $64.22 |
| Revenue Growth | N/A | ★ 4.43 |
| 52 Week Low | $0.71 | $10.37 |
| 52 Week High | $1.94 | $42.50 |
| Indicator | IFRX | INTG |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 55.34 |
| Support Level | $0.73 | $30.38 |
| Resistance Level | $1.16 | $32.97 |
| Average True Range (ATR) | 0.05 | 1.25 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 83.32 | 90.20 |
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.